University of Bern

Investment thesis

The University of Bern funds interdisciplinary research that translates academic discovery into societal and economic impact, with a strategic agenda spanning health resilience, climate adaptation, and digital innovation. It operates as a public research engine rather than a commercial investor, prioritising projects that strengthen Swiss competitiveness and address systemic risks. The university channels third-party funding (CHF 367m) to support early-stage proof-of-concept work and industry-academia partnerships. Credibility: The university’s own website details its research focus on health, climate, and digital technologies, and highlights specific funded initiatives like the Inno Grants for societal transformation and the AI warning system for postoperative infections.

Value add

Beyond funding, applicants gain access to university labs, interdisciplinary networks, and the Innovation Office’s advisory services for project structuring and IP strategy. The university’s credibility enhances follow-on funding eligibility from national and EU bodies. Fit verdict: Strong for startups needing early-stage validation, industry partnerships, or access to specialized research facilities. Founder diligence script: 1. What specific Inno Grant or third-party call aligns with my project’s stage? 2. Does the Innovation Office offer IP guidance for university-industry collaborations? 3. What are the reporting requirements for grant recipients? 4. How does the university handle data sharing in collaborative projects? 5. Are there follow-on funding pathways from Swiss National Science Foundation or EU programmes?

Portfolio focus

• AI-driven health tools, including the postoperative infection warning system. [1]
• Climate adaptation research, such as studies on biodiversity and heat stress. [1]
• Digital technology projects, like the AI model for medical diagnostics. [1]
• Societal transformation initiatives, including food systems and sustainable energy. [1]
• Interdisciplinary health research, focusing on epidemiology and microbiome therapies. [1]